Milestone Pharmaceuticals...

NASDAQ: MIST · Real-Time Price · USD
1.68
-0.03 (-1.75%)
At close: Aug 22, 2025, 1:44 PM

Milestone Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-55.53M -51.93M -41.52M -42.77M -48.41M -55.09M -59.69M -59.25M -58.73M -59.33M -58.39M -62.09M -61.76M -44.35M -42.85M -34.63M -32.39M -46.14M
Depreciation & Amortization
106K 104K 105K 611K 610K 608K 598K 81K 84K 84K 89K 97K 94K 93K 93K 95K 94K 96K
Stock-Based Compensation
5.53M 5.62M 5.78M 6.18M 7.65M 8.75M 9.53M 9.8M 9.31M 9.23M 9.05M 8.88M 8.52M 8.03M 7.28M 6.73M 6.05M 5.33M
Other Working Capital
-2.75M -820.87K 504.13K 3.67M 3.68M 5.91M 4.61M -502.38K 691.29K -1.15M -596.98K 3.24M 5.62M 3.66M 2.61M 152K -2.64M -5.41M
Other Non-Cash Items
3.47M 4.03M 7.23M 12.81M 12.86M 12.2M 8.1M 1.69M 3.68M 5.53M 7.92M 50.73M 49.41M 48.58M 47.81M 54.92M 54.22M 52M
Deferred Income Tax
n/a n/a n/a -5.6M -5.62M -5.62M -5.62M -28K -2.83M -5.54M -5.54M -48.39M -45.56M -42.85M -42.85M -49.97M -49.97M -49.97M
Change in Working Capital
6.04M 8.31M 2.83M 811.31K -185.69K 1.55M 1.23M -1.78M -417K -2.4M -3.26M 1.13M 3.34M 1.52M 2.26M -1.8M -1.3M -4.41M
Operating Cash Flow
-40.38M -33.87M -28.85M -31.23M -36.37M -40.88M -45.85M -49.49M -48.9M -52.42M -52.47M -51.98M -49.8M -34.7M -33.22M -29.6M -27.55M -45.12M
Capital Expenditures
-26.05K -22.05K -22.05K -29.7K -54.65K -78.64K -110.64K -191K -276K -304K -272K -162K -59K n/a n/a 51K 123K 123K
Cash Acquisitions
n/a n/a n/a -53.87M -43.03M -15.03M -15.03M 55.74M 61.85M 33.85M 33.85M 16.95M n/a n/a n/a n/a n/a n/a
Purchase of Investments
-44.65M -61.92M -113.55M -139.23M -135.31M -173M -135.49M -118.74M -132.85M -92.85M -85.85M -47.95M -23M -8M n/a -45M -58M -58M
Sales Maturities Of Investments
114.04M 130.84M 121.87M 141.89M 120.65M 120.85M 140.35M 93M 101M 74M 29M 38M 53M 73M 85M 86M 52M 32M
Other Investing Acitivies
n/a n/a -52.51M -52.51M -63.35M -91.35M -38.84M -55.74M -61.85M -48.85M -56.85M -54.95M -15M 20M 40M 54.95M 31.88M -20.12M
Investing Cash Flow
69.34M 68.88M 8.28M 2.62M -14.72M -52.23M 4.75M -25.93M -32.13M -19.16M -57.12M -25.11M 14.94M 50M 70M 41M -6M -58M
Debt Repayment
n/a n/a n/a n/a n/a n/a 50M 50M 50M 50M n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
27.21M 27.16M 31.94M 4.63M 5.04M 2.3M -2.22M -2M 369.05K 3.29M 3.09M 2.95M 305K 5.08M 5.05M 28.2M 53M 48.25M
Financial Cash Flow
274K -60K 32.12M 32.1M 32.33M 29.86M 47.79M 48.02M 50.38M 53.29M 3.09M 2.95M 305K 5.08M 5.05M 53.12M 77.91M 73.17M
Net Cash Flow
29.24M 34.95M 11.55M 2.92M -19.33M -63.82M 6.12M -27.41M -30.65M -18.29M -106.5M -74.14M -34.56M 20.38M 41.83M 64.52M 44.37M -29.96M
Free Cash Flow
-40.42M -33.9M -28.88M -31.27M -36.42M -40.96M -45.96M -49.68M -49.18M -52.73M -52.74M -52.15M -49.86M -34.7M -33.22M -29.55M -27.42M -45M